Ibio Inc (NYSE American:IBIO)

1.73
Delayed Data
As of 3:59pm ET
 +0.02 / +1.17%
Today’s Change
0.23
Today|||52-Week Range
7.45
+64.76%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$370.6M

Company Description

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the iBio, Inc. and iBio CDMO business segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX.

Contact Information

iBio, Inc.
600 Madison Avenue
New York New York 10022
P:(302) 355-0650
Investor Relations:
(646) 274-3580

Employees

Shareholders

Mutual fund holders7.06%
Individual stakeholders3.84%
Other institutional1.05%

Top Executives

Thomas F. IsettExecutive Chairman, President & CEO
Randy J. MadduxChief Operating Officer
John DeltaChief Financial & Accounting Officer
Martin B. BrennerChief Scientific Officer
Robert B. KaySecretary, Treasurer & Director